Antidepressants and pregnancy: What parents-to-be should know about ADHD, autism risks

Antidepressants in Pregnancy: Risks for ADHD, Autism?

New Study Examines Antidepressants and Pregnancy Risks for ADHD, Autism

Antidepressants and pregnancy – A recent analysis of existing research has offered a more nuanced understanding of the link between antidepressant use during pregnancy and neurodevelopmental disorders such as attention deficit hyperactivity disorder (ADHD) and autism. The study, published in The Lancet Psychiatry, reviews data from 37 prior investigations covering over 600,000 pregnancies where antidepressants were prescribed and nearly 25 million pregnancies without such medication. By accounting for medication type, dosage, and timing, along with genetic and environmental influences, researchers aimed to clarify whether antidepressants significantly elevate the risk of ADHD or autism in offspring.

Antidepressants and Pregnancy: Maternal Use May Slightly Increase Risks

Initial findings suggested a correlation between maternal antidepressant use and higher rates of ADHD and autism in children. Specifically, the study found a 35% increased chance of ADHD and a 69% elevated risk of autism for children exposed to antidepressants in the womb. However, these associations diminished when researchers controlled for factors like family history, genetic predispositions, and the reasons for antidepressant prescriptions. After adjustments, the autism risk was reduced to about 15%, indicating that much of the earlier concern may stem from shared family traits rather than the drugs themselves.

Dr. Wing Chung Chang, a co-senior author and clinical professor at the University of Hong Kong, noted that the study highlights the importance of genetic and environmental factors in neurodevelopmental outcomes. “The observed patterns suggest that the increased rates of ADHD and autism in exposed groups are largely influenced by familial risks, not the medications alone,” he explained in a written statement. This insight reassures parents considering antidepressants while emphasizing the need to balance mental health treatment with fetal development considerations.

Antidepressants in Pregnancy: A Cornerstone for Mood Management

Despite concerns, antidepressants remain a critical treatment for depressive disorders, which affect over 10% of pregnant women globally. Dr. Chang stressed that these medications are essential for preventing complications from untreated mental health conditions. Clinical guidelines typically recommend continuing antidepressant therapy during pregnancy to ensure maternal well-being, especially when the benefits outweigh potential risks.

SSRIs, a common class of antidepressants, have faced scrutiny due to their association with autism, miscarriage, and other birth defects. The July 2025 FDA panel discussions amplified these worries, leading to increased public debate. However, experts argue that the risks are often overstated, and antidepressants are vital for managing mental health during pregnancy. “The focus on risks has sometimes overshadowed the importance of treating maternal depression,” said Dr. Jonathan Alpert, a psychiatrist at Montefiore Medical Center, in an email.

Reassessing Antidepressants and Pregnancy: Addressing Previous Study Limitations

Earlier studies on antidepressants and pregnancy often overlooked key variables, such as family medical history and the underlying reasons for drug use. Dr. Chang pointed out that this inconsistency led to a fragmented view of the issue. The new meta-analysis sought to resolve these gaps by systematically evaluating all relevant data, ensuring a more accurate assessment of how antidepressants interact with other factors to influence neurodevelopmental outcomes.

While the findings do not eliminate concerns about antidepressant use during pregnancy, they provide a clearer picture of the risks. This helps parents and healthcare providers make informed decisions. “The study’s results underscore the complexity of the relationship between antidepressants and pregnancy,” Chang concluded. “It’s not just the medication, but a combination of factors that contribute to developmental conditions like ADHD and autism.”

Antidepressants and Pregnancy: The Debate Over Medication Overuse

The study also aligns with broader conversations about antidepressant overuse. Prominent critics, such as Robert F. Kennedy Jr., have raised alarms about the widespread prescription of these drugs during pregnancy. His advocacy highlights fears that antidepressants could cause long-term developmental issues, even as the research suggests the risks are influenced by genetic and environmental factors. The findings offer a balanced perspective, acknowledging the role of medications while emphasizing the need for a holistic approach to assessing risks during pregnancy.